1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)
    Meeting Abstract

    González Martín, A.; Pothuri, B.; Vergote, I. B.; Christensen, R. D.; Graybill, W.; Mirza, M. R.; McCormick, C.; Lorusso, D.; Hoskins, P.; Freyer, G.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with metastatic Merkel cell carcinoma receiving second-line or later avelumab treatment: 36-month follow-up data
    Meeting Abstract

    D'Angelo, S. P.; Nolte, S.; Schlichting, M.; Henry-Szatkowski, M.; Hennessy, M.; Bharmal, M.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Updated efficacy and safety of melflufen in patients with relapsed/refractory multiple myeloma refractory to daratumumab and/or pomalidomide: HORIZON (OP-106)
    Meeting Abstract

    Richardson, P. G.; Oriol, A.; Larocca, A.; Rodriguez-Otero, P.; Norkin, M.; Blade, J.; Cavo, M.; Hassoun, H.; Leleu, X.; Alegre, A.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • The PI3K inhibitor ME-401 +/- rituximab in relapsed/refractory (R/R) follicular lymphoma (FL), chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
    Meeting Abstract

    Pagel, J.; Zelenetz, A.; Reddy, N.; Jagadeesh, D.; Stathis, A.; Salman, H.; Soumerai, J.; Kenkre, V.; Asch, A.; Jhangiani, H.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Patient-reported outcomes from patients with Waldenstrom macroglobulinemia treated with ibrutinib-rituximab: Results from iNNOVATE study
    Meeting Abstract

    Matous, J. V.; Tedeschi, A.; Dimopoulos, M. A.; Trotman, J.; Garcia-Sanz, R.; Macdonald, D.; Mahe, B.; Herbaux, C.; Heffner, L.; Tam, C. S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Cardiac ALL: Most unusual occurrence of lenalidomide-associated acute lymphoblastic leukemia with subsequent cardiac unvolvement
    Journal Article

    Sharma, N.; Hassoun, H.; Hatem, J.; Kouides, P.
    Cureus (2019)

    Fulltext@MSK | Save
  • Follicular lymphoma: Recent and emerging therapies, treatment strategies, and remaining unmet needs
    Review

    Matasar, M. J.; Luminari, S.; Barr, P. M.; Barta, S. K.; Danilov, A. V.; Hill, B. T.; Phillips, T. J.; Jerkeman, M.; Magagnoli, M.; Nastoupil, L. J.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Towards individualized therapy for metastatic renal cell carcinoma
    Review

    Kotecha, R. R.; Motzer, R. J.; Voss, M. H.
    Nature Reviews Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma
    Journal Article

    von Tresckow, B.; Fanale, M.; Ardeshna, K. M.; Chen, R.; Meissner, J.; Morschhauser, F.; Moskowitz, C.; Zinzani, P. L.; Giezek, H.; Balakumaran, A.; more...
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save